Positive topline results were announced from a phase 3 study of obinutuzumab in patients with lupus nephritis.
Debaters Andres Chang, MD, PhD, and Jean Louise Koff, MD, MS, led the verbal battle at the Debates and Didactics in Hematology and Oncology Conference held from July 25 to 28, 2024, in Sea Island, ...
Examples of immunotherapy are Rituxan (rituximab), Gazyva (obinutuzumab), and Arzerra (ofatumumab). Chemotherapy medications kill rapidly dividing cells. Unfortunately, chemotherapy can’t tell the ...